6 Result(s)
-
Chapter
Liver Transplantation
Liver transplantation is definitive therapy for acute and chronic liver failure. Patient 1-year survival rates following orthotopic liver transplantation (OLT) are now 80% to 90% [1]. According to the United N...
-
Chapter
Management of the Patient Awaiting Liver Transplantation
Close monitoring of patients’ overall status and interventions, such as prompt recognition of GI bleeding or SBP, is crucial to increase the likelihood of a patient surviving to benefit from OLT, the curative ...
-
Chapter
Therapies for Hepatitis B Virus: Current Status and Future Possibilities
On a world-wide basis the hepatitis B virus (HBV) is the most significant viral pathogen affecting man; several hundred million people are infected. Although the chief burden of illness is felt in certain area...
-
Chapter
Long-Term Comparison of Immunosuppressive Therapy with Antithymocyte Globulin to Bone Marrow Transplantation in Aplastic Anemia
Treatment recommendations for aplastic anemia are based on long-term survival data for recipients of syngeneic or allogeneic bone marrow transplants (BMT) and the more recent results of “immunosuppressive ther...
-
Chapter and Conference Paper
Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle
Marrow transplantation for the treatment of severe aplastic anemia has to be viewed in the context of alternate therapies for this disease. An earlier study of the International Aplastic Anemia Study Group sho...
-
Chapter and Conference Paper
Chronic Graft-versus-Host Disease: Pathogenesis, Diagnosis, Treatment, and Prognostic Factors
Chronic graft-versus-host disease (GVHD) and associated infections are major determinants of late morbidity and mortality in 25–50% of long-term survivors of allogeneic marrow transplantation [1]. With improvi...
